amikacin has been researched along with Community Acquired Infection in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (17.39) | 18.2507 |
2000's | 9 (39.13) | 29.6817 |
2010's | 8 (34.78) | 24.3611 |
2020's | 2 (8.70) | 2.80 |
Authors | Studies |
---|---|
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
Alfa, M; Kibsey, P; Loo, V; McGeer, A; Nigrin, J; Peirano, G; Pienaar, C; Pitout, JD; Richardson, D; Toye, B | 1 |
Habib, A; Qadir, A | 1 |
Adeleke, G; Egbagbe, E; Ejembi, J; Ettu, AO; Habib, A; Irowa, OO; Makanjuola, OB; Medugu, N; Mutiu, B; Ogunbosi, B; Ogunsola, F; Oladele, RO; Osinaike, T; Rotimi, V; Uwaezuoke, NS | 1 |
Arnaud, E; Larcher, R; Lavigne, JP; Pantel, A; Sotto, A | 1 |
Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Badal, RE; Hackel, MA; Lob, SH; Sahm, DF | 1 |
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P | 1 |
Luemsamran, P; Mekanandha, P; Pornpanich, K; Vangveeravong, S | 1 |
Azim, A; Baronia, AK; Dwivedi, M; Dwivedi, UN; Mishra, A; Prasad, A; Prasad, KN; Singh, RK | 1 |
Baudrand, H; Devouassoux, G; Freymond, N; Marcu, M; Mbatchou Ngahane, BH; Pacheco, Y | 1 |
Barthélémy, C; De Broucker, M; Décaudin, B; Dubreuil, L; Lannoy, D; Odou, MF; Odou, P; Poret, E; Simon, N | 1 |
Asensi, MD; Carvalho-Assef, AP; Correal, JC; Goldemberg, DC; Leão, RS; Marques, EA; Silva, RV | 1 |
Astal, Z; El-Manama, A; Sharif, FA | 1 |
Abid, F; Ali Lachtar, M; Ayadi, A; Bedoui, A; Ben Homouda, H; Boussoffara, R; Braham, M; Mahjoub, B; Methlouthi, J; Sfar, MT | 1 |
Akin, ES; Bilgiç, H; Ekiz, K; Seber, O; Taşan, Y | 1 |
Abadie, V; Cheron, G; Coustere, C; Gaillard, JL; Hubert, P; Lacaille, F; Le Masne, A; Mahut, B; Matha, V; Silly, C | 1 |
Sanders, CV | 1 |
Beuscart, C; Mouton, YJ | 1 |
Harada, M; Kataoka, M; Kawata, N; Matsuo, K; Nabe, M; Okamoto, M; Tada, S; Takeuchi, M; Yamadori, I | 1 |
3 trial(s) available for amikacin and Community Acquired Infection
Article | Year |
---|---|
Impact of infusion method on amikacin serum levels in humans.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Community-Acquired Infections; Female; Half-Life; Humans; Infusion Pumps; Infusions, Intravenous; Lung Diseases; Male; Middle Aged; Time Factors; Tissue Distribution | 2010 |
Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: a review.
Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam | 1994 |
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbapenems; Ceftazidime; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Respiratory Tract Infections; Sepsis; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections | 1995 |
20 other study(ies) available for amikacin and Community Acquired Infection
Article | Year |
---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
Topics: Bacterial Typing Techniques; beta-Lactamases; Canada; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections | 2010 |
Frequency and Antibiotic Susceptibility Pattern of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) in Uncomplicated Skin and Soft Tissue Infections.
Topics: Agar; Amikacin; Animals; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Female; Furunculosis; Humans; Impetigo; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin | 2022 |
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acquired Infections; Critical Illness; Cross Infection; Fluconazole; Humans; Meropenem; Microbial Sensitivity Tests; Nigeria; Piperacillin, Tazobactam Drug Combination; Pneumonia; Prospective Studies; Urinary Tract Infections | 2023 |
First report of cavitary pneumonia due to community-acquired Acinetobacter pittii, study of virulence and overview of pathogenesis and treatment.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Animals; Caenorhabditis elegans; Community-Acquired Infections; Cross Infection; Female; France; Humans; Middle Aged; Multilocus Sequence Typing; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Virulence | 2017 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011-2014.
Topics: Adolescent; Amikacin; Appendicitis; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Europe; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant; Male; Microbial Sensitivity Tests | 2017 |
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections | 2017 |
Orbital cellulitis and endophthalmitis in pseudomonas septicemia.
Topics: Administration, Topical; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Community-Acquired Infections; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Infusions, Intravenous; Injections; Orbital Cellulitis; Pseudomonas aeruginosa; Pseudomonas Infections; Vitreous Body | 2008 |
Aeromonas caviae septicemia in immunocompetent gastrointestinal carriers.
Topics: Aeromonas; Amikacin; Anti-Bacterial Agents; Bacteremia; Carrier State; Community-Acquired Infections; Digestive System; Feces; Gram-Negative Bacterial Infections; Humans; Immunocompetence; India | 2008 |
[Lung abscess due to community acquired Klebsiella pneumonia].
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Community-Acquired Infections; Comorbidity; Diabetes Mellitus; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lung Abscess; Male; Middle Aged; Piperacillin; Radiography, Thoracic; Shock, Septic; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
KPC-2 producing Klebsiella pneumoniae and Escherichia coli co-infection in a catheter-related infection.
Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Catheter-Related Infections; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pneumonia, Bacterial; Thienamycins | 2011 |
Antibiotic resistance of bacteria associated with community-acquired urinary tract infections in the southern area of the Gaza Strip.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle East; Urinary Tract Infections | 2002 |
[Severe community acquired pneumonia due to Staphylococcus aureus in children. About two cases].
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Community-Acquired Infections; Female; Follow-Up Studies; Fosfomycin; Humans; Pneumonia, Staphylococcal; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
A case of Acinetobacter calcoaceticus pneumonia.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Amikacin; Ceftriaxone; Community-Acquired Infections; Diagnosis, Differential; Humans; Male; Pneumonia, Bacterial | 1995 |
Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis.
Topics: Amikacin; Child; Child, Preschool; Community-Acquired Infections; Female; Glucose; Humans; Infant; Male; Meningitis, Bacterial | 1995 |
[Pulmonary Nocardia otitidiscaviarum infection in an immunocompetent host].
Topics: Aged; Amikacin; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Humans; Immunocompromised Host; Male; Nocardia; Nocardia Infections; Pneumonia; Treatment Outcome | 2000 |